Close Menu
Home › Saga Diagnostics Raises $4.2M

Saga Diagnostics Raises $4.2M

Jun 11, 2019
|
staff reporter

NEW YORK (GenomeWeb) — Swedish liquid biopsy firm Saga Diagnostics said today that it has raised SEK 40 million ($4.2 million) in venture financing.

Hadean Ventures led the round with participation from existing investors including Fårö Capital and the Gunnar Nilsson Cancer Foundation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

What's Popular?

In Molecular Diagnostics

  1. Quest Diagnostics Acquires Blueprint Genetics

  2. Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

  3. Sysmex Wins Chinese Approval for Breast Cancer IVD Reagent

  4. Abbott Q4 Diagnostics Revenues up 5 Percent, MDx Revenues Decline

  5. Adaptive Biotechnologies Announces Preliminary FY19 Revenue Increase, $257M Stock Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.